boston pharmaceuticals gsk

News

GSK to buy liver disease drug from Boston Pharmaceuticals

GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion

The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their exclusivity periods.

PMLive · 1h

GSK to acquire Boston’s liver disease candidate efimosfermin in deal worth up to $2bn

· 21h · on MSN

GSK to buy liver disease drug for up to $2 billion

Pharmabiz7h

GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD

GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD: London, UK Thursday, May 15, 2025, ...

1don MSN

GSK to buy efimosfermin for up to $2 billion

British pharmaceutical giant GSK on Wednesday said it will buy efimosfermin, a phase III-ready potential specialty medicine ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

GSK to buy liver disease drug from Boston Pharmaceuticals

Trending now